- Home
- APRE vs FLGC Comparison
APRE vs FLGC Comparison
Compare APRE & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- FLGC
- Stock Information
- Founded
- APRE 2006
- FLGC 2019
- Country
- APRE United States
- FLGC United States
- Employees
- APRE N/A
- FLGC N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- APRE Health Care
- FLGC Health Care
- Exchange
- APRE Nasdaq
- FLGC Nasdaq
- Market Cap
- APRE 21.2M
- FLGC 17.3M
- IPO Year
- APRE 2019
- FLGC 2021
- Fundamental
- Price
- APRE $2.62
- FLGC $0.87
- Analyst Decision
- APRE Strong Buy
- FLGC Strong Buy
- Analyst Count
- APRE 2
- FLGC 4
- Target Price
- APRE $15.50
- FLGC $5.67
- AVG Volume (30 Days)
- APRE 35.9K
- FLGC 276.0K
- Earning Date
- APRE 03-25-2025
- FLGC 03-27-2025
- Dividend Yield
- APRE N/A
- FLGC N/A
- EPS Growth
- APRE N/A
- FLGC N/A
- EPS
- APRE N/A
- FLGC N/A
- Revenue
- APRE $1,310,839.00
- FLGC $64,154,000.00
- Revenue This Year
- APRE $134.21
- FLGC N/A
- Revenue Next Year
- APRE N/A
- FLGC $8.94
- P/E Ratio
- APRE N/A
- FLGC N/A
- Revenue Growth
- APRE 130.31
- FLGC N/A
- 52 Week Low
- APRE $2.15
- FLGC $0.72
- 52 Week High
- APRE $8.85
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- APRE 30.05
- FLGC 45.99
- Support Level
- APRE $2.59
- FLGC $0.80
- Resistance Level
- APRE $3.72
- FLGC $0.99
- Average True Range (ATR)
- APRE 0.35
- FLGC 0.09
- MACD
- APRE -0.13
- FLGC 0.02
- Stochastic Oscillator
- APRE 1.41
- FLGC 39.16
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.